English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Don't miss 'Highlights of ESH-iCMLf 2022' on Oct 26th at 14.00 CEST
October 2022 - The 24th John Goldman Conference is just around the corner – again with an excellent scientific program and new, often unpublished data on CML. If you can’t attend the live program, or would like a recap after the conference, then join us to discuss clinical and biological highlights of the meeting during an iCMLf Conversation.
On Wednesday, October 26th at 14.00 Central European Summer Time, meeting co-chairs, Professor Jorge Cortes and Professor Daniela Krause, will provide an overview of the significant clinical and biological aspects presented during the conference. There will also be plenty of time for your questions and an open discussion.
Don’t miss this opportunity and save the date.
Meet Dr Ali Bazarbachi One of This Year's iCMLf Prize Nominees
The first featured iCMLf Prize nominee is Dr Ali Bazarbachi, American University of Beirut, Lebanon
“CML is predicted to become the most prevalent leukemia by 2040 and accordingly an intensive global effort with more international collaborations between clinicians and researchers is imperative to find a definitive cure for CML.”
Ali Bazarbachi, MD, PhD is a Professor of Medicine (Hematology and Oncology), Professor of Anatomy, Cell Biology and Physiological Sciences, and Director of the bone marrow transplantation program at the American University of Beirut-Medical Center.
Featuring outstanding work in CML in low and middle-income countries
As part of the iCMLf’s mission to improve outcomes for people with CML around the world we are taking the opportunity to feature the achievements of those who work in the most resourced challenged areas.
“We rise by lifting others” – Robert Ingersoll
Earlier this year we continued the tradition of awarding the iCMLf Prize to people who dedicate their time and effort through research, study and humanitarianism, as a means to change the lives of those impacted by CML, specifically those in low and middle-income countries.
World CML Day 9/22 - Towards a Cure for CML
United in community and purpose - Towards a Cure for CML
On World CML Day 9/22 - We reflect on how much has been done and yet there is still much still to do!
See our message for World CML Day from the iCMLf
Send us your questions - 'Meet-the-CML-Experts' webinar on Sept 21st
September 2022 - Our ‘Meet-the-CML-Experts’ iCMLf Conversation this year is getting closer. And we hope to see you there!
During this 45-min Q&A session on September 21st at 2 pm CEST, you will have the chance to ask your questions related to CML management, CML research and future developments to our panel of experts to get their first-hand expert opinion. If you are a physician from a low and middle-income country, you may also address the specific challenges of CML management in a low-resource setting.
Get in first and submit your questions now!
We are pretty sure you have a lot of burning questions. But before you send them in, we’d like to introduce you to our panel of experts and to provide you with an overview of their main areas of expertise.
Invitation: An iCMLf Conversation - Treatment after failure of 2 TKIs
July 2022 - Please save the date for our next iCMLf Conversation with Professor Andreas Hochhaus on Wednesday, August 24th at 2 pm Central European Summer Time.
iCMLf Conversation –
Treatment of CML patients after failure of 2 TKIs
Hear about current practices for third-line management of CML and get first-hand expert knowledge from:
Professor Andreas Hochhaus
Head of the Department of Hematology and Medical Oncology
Jena University Hospital (Germany)
Date: August 24th at 2 pm Central European Summer Time(CEST)
